1Berger J, Moller D E. The mechanisms of action of PPARS. Annu Rev Med,2002,339:953-959.
2Beamer B A, Negri C, Yen C J, et al. Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-γ (hPPARγ) gene. Biochem Biophys Res Commun,1997,233:756-759.
3Hsu M H, Palmer C N A, Song W, et al. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J Bio Chem,1998,273:27988-27997.
4Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev,1999,20:649-689.
5Olefsky J M. Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J Clin Invest,2000,106: 467-472.
6Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet,1999,354: 141-148.
7Jackson S M, Parhami F, Xi X P, et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol ,1999,19: 2094-2104.
8Neve B P, Fruchart J C, Staels B. Role of the peroxisome proliferator-activated receptors(PPAR) in atherosclerosis. Biochemical Pharmacol,2000,60: 1245-1250.
9Sugqwara A, Takeuchi K, Uruno A, et al.Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin Ⅱtype 1 receptor genes. Hypertens Res,2001,24:229-233.
10Benson S, Wu J, Padmanabhan S, et al. Peroxisome proliferator-activated receptor(PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor(PPAR)-ga
5Chang PC,Chen TH.Chang CJ,et al.advanced glyeosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.Kidney Int,2004,65(5):1665-1675.
6Gruden G,Setti G,Hayward A,et al.Mechanical stretch induces monocyte chemoattractant activity via an NF-κB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells:inhibition by rosiglitazone.J Am Soc Nephrol,2005,16 (3):688-696.
8Monaco C,Paleolog E.Nuclear factor kappaB:a potential therapeutic target in atherosclerosis and thrombosis.Cardiovasc Res,2004,61 (4):671-821.
9Shin YH,Shim J,Hur MW,et al.Involvement of two NF-kappaB binding sites in PMA-induced expression of the human leukotactin-1/CCL15 gene in U937 monocytoid cells.Mol Cells,2004,17 (2):316-321.
10Beg AA,Baltimore D.An essential role for NF-κB in preventing TNF-α-induced cell death.Science,1996,274 (5288):782-784.
